Tchort
Bluelight Crew
- Joined
- Mar 25, 2008
- Messages
- 2,390
Drug addicts could benefit from an Implanon-style buprenorphine implant that overcomes many of the problems of the current sublingual tablet addiction treatment, an Australian pilot trial suggests.
The opioid receptor agonist has been formulated in a matchstick subdermal implant that provides a steady state of the drug and which has proved effective in preventing cravings and withdrawal symptoms, a study in three Australian treatment centres has shown.
And unlike the sublingual tablets of buprenorphine the implant avoids the risk of diversion and reduced the problems of non-compliance and the need for regular clinic or pharmacy visits, say the authors of a study published in the journal Drug and Alcohol Dependence (103: 37-43).
The pilot study in 12 heroin-dependent drug users who were already using sublingual buprenorphine found that they could be switched smoothly to the implant and their cravings and withdrawal symptoms remained at a low level for the six month duration of the implants.
Risks of illicit diversion are low because the drug is implanted under the skin and would difficult for users to remove. In addition, the use of a polymer matrix means the drug cannot be extracted for illicit IV use such as by soaking in water.
Users in the trial said they preferred the implant over sublingual tablets because the flat drug levels meant they did not experience opioid-like highs or withdrawal lows over the trial. The implants also proved safe, with only minimal injection site reactions. The study authors say the implants can be inserted and removed as a routine procedure by any medical practitioner with appropriate training, and could therefore be offered in a wide variety of settings, such as primary care, rather than restricted to specialist treatment or addiction centres.
http://www.6minutes.com.au/articles/z1/view.asp?id=482589
6Minutes.com.au
5/25/2009
By Michael Woodhead
Buprenorphine Implants Show Promise
Last edited:


